GR870413B - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number: GR870413B
Authority: GR; Greece
Prior art keywords: pharmaceutical formulation; formulation; pharmaceutical
Prior art date: 1986-03-15

Application number

GR870413A

Other languages

English (en)

Inventor

Hugh Cairns

Original Assignee

Fisons Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-03-15

Filing date

1987-03-12

Publication date

1987-07-10

1986-03-15 Priority claimed from GB868606455A external-priority patent/GB8606455D0/en

1986-03-17 Priority claimed from GB868606553A external-priority patent/GB8606553D0/en

1987-03-12 Application filed by Fisons Plc filed Critical Fisons Plc

1987-07-10 Publication of GR870413B publication Critical patent/GR870413B/el

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

GR870413A 1986-03-15 1987-03-12 Pharmaceutical formulation GR870413B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB868606455A GB8606455D0 (en)	1986-03-15	1986-03-15	Formulations
GB868606553A GB8606553D0 (en)	1986-03-17	1986-03-17	Pharmaceutical mixtures

Publications (1)

Publication Number	Publication Date
GR870413B true GR870413B (en)	1987-07-10

Family

ID=26290497

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR870413A GR870413B (en)	1986-03-15	1987-03-12	Pharmaceutical formulation

Country Status (18)

Country	Link
EP (1)	EP0241134B1 (el)
JP (1)	JP2594268B2 (el)
AU (1)	AU599962B2 (el)
BE (1)	BE1001229A3 (el)
CA (1)	CA1276557C (el)
CH (1)	CH674936A5 (el)
DE (1)	DE3774157D1 (el)
ES (1)	ES2039433T3 (el)
FR (1)	FR2598617B1 (el)
GB (1)	GB2187953B (el)
GR (1)	GR870413B (el)
HK (1)	HK14393A (el)
IE (1)	IE59811B1 (el)
IL (1)	IL81888A (el)
LU (1)	LU86809A1 (el)
MX (1)	MX172943B (el)
NZ (1)	NZ219557A (el)
SG (1)	SG119892G (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8630419D0 (en) *	1986-12-19	1987-01-28	Fisons Plc	Pharmaceutical formulation
GB2202145B (en) *	1987-03-17	1991-01-02	Fisons Plc	Compositions of nedocromil for dermatological use.
GB8712251D0 (en) *	1987-05-23	1987-07-01	Fisons Plc	Formulation
US5248493A (en) *	1988-08-27	1993-09-28	Fisons Plc	Pharmaceutical composition
GB8820398D0 (en) *	1988-08-27	1988-09-28	Fisons Plc	Pharmaceutical formulation
GB8911259D0 (en) *	1989-05-17	1989-07-05	Fisons Plc	Inhalation medicament
US5198221A (en) *	1989-05-17	1993-03-30	Fisons Plc	Pharmaceutical composition
US5270305A (en)	1989-09-08	1993-12-14	Glaxo Group Limited	Medicaments
US5208226A (en) *	1989-09-08	1993-05-04	Glaxo Group Limited	Medicaments
AU6290396A (en) *	1995-06-29	1997-01-30	Mcneil-Ppc, Inc.	The combination of topical nasal mast cell stabilizers and topical nasal steroids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA812811B (en) *	1980-04-30	1982-06-30	Fisons Ltd	Mixtures and salts of beta-2 selective bronchodilators with cromoglycic acid and salts thereof
JPS5712000A (en) *	1980-05-20	1982-01-21	Schering Plough Corp	Beclomethasone solvation
EP0162556B1 (en) *	1984-04-13	1991-11-06	FISONS plc	Novels forms and formulations of nedocromil sodium

1987
- 1987-03-05 GB GB8705111A patent/GB2187953B/en not_active Expired
- 1987-03-06 ES ES198787301947T patent/ES2039433T3/es not_active Expired - Lifetime
- 1987-03-06 DE DE8787301947T patent/DE3774157D1/de not_active Expired - Fee Related
- 1987-03-06 EP EP87301947A patent/EP0241134B1/en not_active Expired - Lifetime
- 1987-03-09 CA CA000531540A patent/CA1276557C/en not_active Expired - Fee Related
- 1987-03-10 NZ NZ219557A patent/NZ219557A/xx unknown
- 1987-03-12 CH CH928/87A patent/CH674936A5/fr not_active IP Right Cessation
- 1987-03-12 GR GR870413A patent/GR870413B/el unknown
- 1987-03-13 IL IL81888A patent/IL81888A/xx not_active IP Right Cessation
- 1987-03-13 IE IE67087A patent/IE59811B1/en not_active IP Right Cessation
- 1987-03-13 MX MX557787A patent/MX172943B/es unknown
- 1987-03-13 AU AU70013/87A patent/AU599962B2/en not_active Ceased
- 1987-03-13 LU LU86809A patent/LU86809A1/fr unknown
- 1987-03-13 JP JP62056946A patent/JP2594268B2/ja not_active Expired - Fee Related
- 1987-03-13 BE BE8700261A patent/BE1001229A3/fr not_active IP Right Cessation
- 1987-03-13 FR FR878703487A patent/FR2598617B1/fr not_active Expired - Fee Related
1992
- 1992-11-16 SG SG1198/92A patent/SG119892G/en unknown
1993
- 1993-02-25 HK HK143/93A patent/HK14393A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
CH674936A5 (el)	1990-08-15
GB2187953B (en)	1989-11-15
JPS62221627A (ja)	1987-09-29
MX172943B (es)	1994-01-25
FR2598617A1 (fr)	1987-11-20
EP0241134B1 (en)	1991-10-30
IE59811B1 (en)	1994-04-06
DE3774157D1 (de)	1991-12-05
GB8705111D0 (en)	1987-04-08
AU7001387A (en)	1987-09-17
SG119892G (en)	1993-02-19
IE870670L (en)	1987-09-15
LU86809A1 (fr)	1987-08-12
ES2039433T3 (es)	1993-10-01
GB2187953A (en)	1987-09-23
MX5577A (es)	1993-04-01
IL81888A (en)	1991-12-12
CA1276557C (en)	1990-11-20
EP0241134A1 (en)	1987-10-14
AU599962B2 (en)	1990-08-02
NZ219557A (en)	1990-05-28
FR2598617B1 (fr)	1990-07-27
HK14393A (en)	1993-03-05
BE1001229A3 (fr)	1989-08-29
JP2594268B2 (ja)	1997-03-26

Publication	Publication Date	Title
GB8610572D0 (en)	1986-06-04	Pharmaceutical preparation
GB8613688D0 (en)	1986-07-09	Pharmaceutical composition
GB8716904D0 (en)	1987-08-26	Stable pharmaceutical preparation
GB8618847D0 (en)	1986-09-10	Pharmaceutical formulations
CS8700282A2 (en)	1991-07-16	Nicorandil-containing stable pharmaceutical
GB2187953B (en)	1989-11-15	Pharmaceutical formulation
GB8711274D0 (en)	1987-06-17	Ketoprofen pharmaceutical formulation
GB8721313D0 (en)	1987-10-14	Pharmaceutical preparation
ZA876048B (en)	1988-04-27	Pharmaceutical formulation
GB8614189D0 (en)	1986-07-16	Pharmaceutical composition
GB8712240D0 (en)	1987-07-01	Pharmaceutical formulation
GB8630419D0 (en)	1987-01-28	Pharmaceutical formulation
ZA9015B (en)	1990-10-31	Pharmaceutical formulation
GB8630769D0 (en)	1987-02-04	Pharmaceutical formulation
GB8630904D0 (en)	1987-02-04	Pharmaceutical formulation
GB8604244D0 (en)	1986-03-26	Pharmaceutical formulation
GB8622482D0 (en)	1986-10-22	Pharmaceutical formulation
GB8624269D0 (en)	1986-11-12	Pharmaceutical formulation
GB8630767D0 (en)	1987-02-04	Pharmaceutical formulation
GB8704660D0 (en)	1987-04-01	Pharmaceutical composition
GB8718131D0 (en)	1987-09-03	Pharmaceutical formulation
GB8708011D0 (en)	1987-05-07	Pharmaceutical formulation
GB8700063D0 (en)	1987-02-11	Pharmaceutical formulation
GB8706683D0 (en)	1987-04-23	Pharmaceutical formulation
GB8706684D0 (en)	1987-04-23	Pharmaceutical formulation